BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32303258)

  • 1. Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma.
    Fontanilles M; Marguet F; Ruminy P; Basset C; Noel A; Beaussire L; Viennot M; Viailly PJ; Cassinari K; Chambon P; Richard D; Alexandru C; Tennevet I; Langlois O; Di Fiore F; Laquerrière A; Clatot F; Sarafan-Vasseur N
    Acta Neuropathol Commun; 2020 Apr; 8(1):52. PubMed ID: 32303258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in
    Felsberg J; Hentschel B; Kaulich K; Gramatzki D; Zacher A; Malzkorn B; Kamp M; Sabel M; Simon M; Westphal M; Schackert G; Tonn JC; Pietsch T; von Deimling A; Loeffler M; Reifenberger G; Weller M;
    Clin Cancer Res; 2017 Nov; 23(22):6846-6855. PubMed ID: 28855349
    [No Abstract]   [Full Text] [Related]  

  • 3. Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas.
    Biernat W; Huang H; Yokoo H; Kleihues P; Ohgaki H
    Brain Pathol; 2004 Apr; 14(2):131-6. PubMed ID: 15193025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining EGFR amplification status for clinical trial inclusion.
    French PJ; Eoli M; Sepulveda JM; de Heer I; Kros JM; Walenkamp A; Frenel JS; Franceschi E; Clement PM; Weller M; Ansell P; Looman J; Bain E; Morfouace M; Gorlia T; van den Bent M
    Neuro Oncol; 2019 Oct; 21(10):1263-1272. PubMed ID: 31125418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and ultrasensitive digital PCR (dPCR) profiling of EGFRvIII in tumor cells and tissues.
    Saxena D; Sheikh S; Kao G; Binder ZA; Alonso-Basanta M; O'Rourke DM; Nasrallah MP; Dorsey JF
    Neurooncol Adv; 2019; 1(1):vdz030. PubMed ID: 31807732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
    Manda SV; Kataria Y; Tatireddy BR; Ramakrishnan B; Ratnam BG; Lath R; Ranjan A; Ray A
    J Neurosurg; 2018 Apr; 128(4):1091-1101. PubMed ID: 28574310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.
    Figueroa JM; Skog J; Akers J; Li H; Komotar R; Jensen R; Ringel F; Yang I; Kalkanis S; Thompson R; LoGuidice L; Berghoff E; Parsa A; Liau L; Curry W; Cahill D; Bettegowda C; Lang FF; Chiocca EA; Henson J; Kim R; Breakefield X; Chen C; Messer K; Hochberg F; Carter BS
    Neuro Oncol; 2017 Oct; 19(11):1494-1502. PubMed ID: 28453784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of glioblastoma harboring non-amplified epidermal growth factor receptor variant III: Critical molecular detection using RNA-based panel analysis.
    Kirishima M; Akahane T; Takajo T; Higa N; Yonezawa H; Uchida H; Kamimura K; Hanaya R; Yoshimoto K; Higashi M; Yoshiura T; Tanimoto A
    Pathol Res Pract; 2023 Aug; 248():154712. PubMed ID: 37499520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry.
    Lee M; Kang SY; Suh YL
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):589-598. PubMed ID: 29912767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development.
    Koga T; Li B; Figueroa JM; Ren B; Chen CC; Carter BS; Furnari FB
    Neuro Oncol; 2018 Sep; 20(10):1310-1320. PubMed ID: 29660021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFRvIII--a stable target for anti-EGFRvIII therapy.
    Banaszczyk M; Stoczynska-Fidelus E; Winiecka-Klimek M; Bienkowski M; Och W; Rieske P; Piaskowski S
    Anticancer Res; 2013 Dec; 33(12):5343-8. PubMed ID: 24324068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.
    Liu L; Bäcklund LM; Nilsson BR; Grandér D; Ichimura K; Goike HM; Collins VP
    J Mol Med (Berl); 2005 Nov; 83(11):917-26. PubMed ID: 16133418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers.
    Faulkner C; Palmer A; Williams H; Wragg C; Haynes HR; White P; DeSouza RM; Williams M; Hopkins K; Kurian KM
    Br J Neurosurg; 2015 Feb; 29(1):23-29. PubMed ID: 25141189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile.
    Lopez-Gines C; Gil-Benso R; Ferrer-Luna R; Benito R; Serna E; Gonzalez-Darder J; Quilis V; Monleon D; Celda B; Cerdá-Nicolas M
    Mod Pathol; 2010 Jun; 23(6):856-65. PubMed ID: 20305620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy.
    Weller M; Kaulich K; Hentschel B; Felsberg J; Gramatzki D; Pietsch T; Simon M; Westphal M; Schackert G; Tonn JC; von Deimling A; Davis T; Weiss WA; Loeffler M; Reifenberger G;
    Int J Cancer; 2014 May; 134(10):2437-47. PubMed ID: 24614983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.
    An Z; Aksoy O; Zheng T; Fan QW; Weiss WA
    Oncogene; 2018 Mar; 37(12):1561-1575. PubMed ID: 29321659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical Bioinformatic DNA-Sequencing Pipeline for Detecting Oncogene Amplification and EGFRvIII Mutational Status in Clinical Glioblastoma Samples.
    Miller ML; Tome-Garcia J; Waluszko A; Sidorenko T; Kumar C; Ye F; Tsankova NM
    J Mol Diagn; 2019 May; 21(3):514-524. PubMed ID: 31000415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.
    López-Ginés C; Navarro L; Muñoz-Hidalgo L; Buso E; Morales JM; Gil-Benso R; Gregori-Romero M; Megías J; Roldán P; Segura-Sabater R; Almerich-Silla JM; Monleón D; Cerdá-Nicolás M
    Cell Oncol (Dordr); 2017 Aug; 40(4):389-399. PubMed ID: 28631186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.
    van den Bent MJ; Gao Y; Kerkhof M; Kros JM; Gorlia T; van Zwieten K; Prince J; van Duinen S; Sillevis Smitt PA; Taphoorn M; French PJ
    Neuro Oncol; 2015 Jul; 17(7):935-41. PubMed ID: 25691693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis.
    Chen JR; Xu HZ; Yao Y; Qin ZY
    Acta Neurol Scand; 2015 Nov; 132(5):310-22. PubMed ID: 25846813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.